Perron flags stroke drug's potential in Alzheimer's treatment

Research by the Perron Institute has found that the flagship product of Perth-based neurological drug developer Argenica Therapeutics, which protects brain tissue from dying immediately after a stroke, may also help treat Alzheimer's disease.